Vol. 15, No. 5, 1964
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
A MOLECULAE DEFECT OF MYELINATION John S. O'Brien University
Received
March
of Southern California, School Los Angeles, California
17, 1564
A molecular a rare
mm, sulfates
hereditary
large
Frozen
separated
methanol
2rl
into
separated
column
into
column
on a analytical the purity
closely taminated
with
acids fatty
(21-26 acids.
carbons) In this
is presented
and the pathogenesis
(2,3).
but report
to
of MLD.
The quantity
and sulfate
Paper
and that
analyses The results
values compounds
indicating were 484
chloroform-
from
each
cerebrosides,
lipid
(1)
and a combination
or with
a silicic
was determined
(1,3,4)
was used
of phosphorus, of these that absent
serine
of a Florisil
column column
cerebroside
phosphatides,
a combination
acid
chromatography
content.
abnormal
using
with
extracts
and ethanolamine
of each
as were
theoretical
The lipid
a silicic
of MLD were
and extracted
(DEAE) cellulose with
two cases
ceramides,
phosphatides
balance.
the
(1).
gangliosides,
column
from
matter,
cholesterol,
of each fraction
hexose
cerebroside
and sphingomyelins
hypothesis
lobes
and white
a diethylaminoethyl
of a DEAE cellulose silicate
the frontal
previously
and choline
with
and a working
grey
sphingomyelins,
phosphatides,
acid,
from
as described
were
fatty
of these
defect
in which
cerebrosides
chain
depleted
leucodystrophy
ANDMETHODS
tissue
manually
formation
matter,
long
the biochemical
MATERIALS
sulfates,
of very
are nearly
in metachromatic
of myelin white
are documented
explain
tissue
disorder In normal
lipids
findings
partially
has been found
proportions
in KLD these these
defect
accumulate.
contain
of Medicine
by weighing to evaluate
glycerol,
analyses
the fractions or undetectable,
acid-
fatty
corresponded were
uncon-
The fatty
Vol. 15, No. 5, 1964
acid
BIOCHEMICAL
compositions
liquid
of the three
chromatography
acetals
after
the
AND BIOPHYSICAL
glycerolphosphatides
(GLC) of fatty latter
hydrolysis
(3,5).
determined
by GLC (6).
acid
acid
were
methyl
had been selectively
The fatty
RESEARCH COMMUNICATIONS
esters
isolated
compositions
determined
by gas-
and aldehyde by mild
dimethyl-
alkaline
of the sphingolipids
were
RESULTS The lipid with
a normal
of total
fold
control
lipid,
gangliosides while
compositions
of a similar
cholesterol, were
cases
were
matter
phosphatides,
diminished. decreased.
and ceramides
from
age are given
choline
somewhat
in Case 2 they in both
of grey
each patient in Table
1. The quantities
sphingomyelins,
In Case 1 cerebrosides Cerebroside
were
sulfates
moderately
compared
and were
were
increased
increased
3-4
increased.
TABLE1 LIPID
COMPOSITION OF FRONTAL LOBE GREY MATTER Case 1 Case 2 Normal
Age 9 11 Total lipid 34.80 39.35 Protein 65.20 60.65 Water 83.34* 84.88 Cholesterol 7.01 5.94 Ethanolamine Phosphatides * 9.05 Serine Phosphatides * 2.64 Choline Phosphatides 6.91 8.15 Sphingomyelins 2.37 2.09 Cerebrosides 3.50 1.26 Cerebroside Sulfates 1.60 1.42 Ceramides 0.63 0.75 Gangliosides * 0.28 All values except water are expressed tialues affected by formalin fixation
In white tides, side
sphingomyelin, sulfates
Cerebrosides were
matter
moderately
were were
total
9 47.80 52.20 85.79 7.21
diminished
9 53.50 46.50 79.91* 10.00
9.61 2.68 8.99 2.77 1.91 0.41 0.48 0.40 as percent
lipid,
11 50.30 49.70 82.05 8.10
9 74.13 25.87 77.35 13.24
* 9.10 * 2.87 7.70 7.60 2.94 2.41 6.41 2.62 12.60 5.33 0.70 1.26 * 0.20 of dry weight.
12.Ik 5.13 8.84 4.93 10.67 3.95 0.50 0.44
cholesterol,
and cerebrosides increased
WRITE MATTER Case 1 Case 2 Normal
were
three-fold
485
markedly
three
glycerolphospha-
decreased
in Case 1 and 1.4 fold
to 25% of normal
increased.
all
in Case 2 while
while
cerebra,
in Case 2. ceramides
Vol. 15, No. 5, 1964
BIOCHEMICAL
In MID, matter
the
fatty
acid
glycerolphosphatides
sphingolipids. larger
proportions
of aldehydes dilution
matter
normal.
of myelin (7-10
fold)
acids
with
21-26
carbons
alpha
hydroxy
acids
since
14-20
carbons
being
striking
diminution
sulfates
from Mu) white
toward
larger
small
compared
by glial
length
(Table
in the proportion
proportions
of long
3).
a shift
of shorter
chain
acids.
or sphingomyelins
fatty
acids
fatty
and
chain
fatty
acids
with
The diminution
the
longer
Ceramides
chain
a
was a striking
the longer
acids;
showed
reflect
containing
2 and 3).
also
to cerebrosides
There
containing
of the fatty
proportions
unsubstituted
for
(Tables
the diminution
matter
cells.
both
was specific
matter somewhat
and probably
and sphingomyelins
or increased
to the chain
of the grey
and smaller
small
and cerebrosides
normal
the greater
were
of the grey
contained
acids
2) involving
The defect
sphingomyelins were
fatty
of cerebrosides
acids*.
those
glycerolphosphatides
matter
(Table
compositons
as were
changes
in MLD white
diminution
acid,
the
These
aldehyde
normal
of polyunsaturated
than
proportional
and fatty
were
In white
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
fatty
showed
acids.
However, (Table
the fatty
also
in fatty
was
a
Cerebroside
acid
composition
this
shift
was
3).
DISCUSSION The biochemical the fatty for
acids
longer
side
in MID appears
of sphingolipids
chain
cerebrosides,
defect
acids
ceramides
(21-26
beyond carbons)
to be a failure
18 carbons. and effects
and sphingomyelins
to elongate
The defect the fatty
much moreso
than
is acids
those
specific of of cerebro-
sulfates. The nature
shown that fatty palmitic
of the defect
two systems
acids, acid
exist
is not
in the
brain
1) a de novo system which (7,B)
and 2) a chain
siThe proportions of total hydroxy sulfates from grey or white matter
completely for
acids were
486
It
the biosynthesis
condenses
elongation
understood.
8 acetate
system
which
has been
of saturated units attaches
to form 2 acetate
in cerebrosides and cerebroside equal to the control.
Vol. 15, No. 5, 1964
BIOCHEMICAL
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
TABLE2 FATTY
(As percent of total
ACID
ACIDS OF SPHINCCLIPIDS 11 unsubstituted fatty acids in each lipid) GREXMATTER
Sphingomyelin Cerebroside Cerebroside Sulfate Case 1 Case 2 Normal Case 1 Case 2 Normal Case 1 Case 2 Normal
14:0 1.6 16~1 tr 16:0 10.3 18:l 3.0 18:0 76.7 2O:l tr 20:o 2.0 22:l tr 22;o 0.3 23:l tr 23:o if9 2411 24:0 2.0 2511 0.9 2510 0.3 2611 tr 26:0 tr 14-20 93.6 21-26 6.4
1.3 tr 17.0 2.9 72.0 tr 1.3 tr 0.7 tr tr 1.7 1.0 tr tr tr tr 94.5 5.5
1.4 tr 9.4 2.2 78.6 tr 1.2 tr 0.5 tr tr 2.9 1.5 0.8 tr tr -92.8 7.2
10.3 tr 20.4 23.0 31.0 tr 0.5 tr 2.0 0.4 0.8 5.0 3.5 1.0 0.7 0.5 0.3 84.8 15.2
2.8 3.7 26.3 23.6 29.6 tr 0.5 0.3 0.1 tr 0.1 1.0 0.6 0.2 0.1 0.3 tr 85.6 14.4
4.7 tr 23.4 21.3 34.3 tr tr tr tr tr tr 4.4 2.1 0.4 tr tr -83.7 16.3
10.8 0.4 17.5 1.8 16.4 tr 1.0 0.3 2.1 0.5 ‘2.1 15.0 11.5 7.4 3.0 8.2 1.7 47.9 52.1
4.7 0.9 18.7 8.5 24.3 tr 1.6 1.1 1.6 0.4 1.4 14.3 14.3 2.9 1.2 2.6 0.5 58.7 41.3
17.2 2.2 20.0 5.0 13.1 0.4 0.2 tr 0.8 tr 1.2 13.0 5.3 3.2 1.3 3.8 tr 57.9 42.1
ACID
WHITEMATTRR Cerebroside Cerebroside Sulfate Sphingomyelin Case 1 Case 2 Normal Case 1 Case 2 Normal Case 1 Case 2 Normal
14x0 1611 16rO 1811 1810 2O:l 2010 22:l 22:o 23:l 23:0 24.1 24:0 25:l 25:0 26:l 26x0 14-20 21-26
3.0 0.8 10.3 3.8 50.0 0.1 0.9 0.1 0.9 0.1 1.0 16.5 3.4 2.5 1.5 3.0 tr 72.6 27.4
1.0 0.3 9.8 1.2 73.8 tr 1.2 -0.8 tr 0.6 7.2 1.7 0.8 tr 1.0 8::6 12.4
7.8 0.5 6.7 1.3 30.5 tr 0.9 0.4 1.4 0.5 1.6 25.2 6.5 3.2 1.4 2.3 tr 57.5 42.5
0.7 1.5 18.1 32.8 26.4 1.3 0.5 0.1 0.3 0.3 0.8 6.8 1.9 1.1 0.3 1.2 tr 84.1 15.9
0.8 2.2 22.8 19.0 25.9 0.3 0.3 0.3 0.6 0.2 0.7 7.3 6.2 2.2 0.3 0.2 0.2 78.0 22.0
units at a time to make longer chain fatty appears to be exclusively
involved
acids (9,lO).
in MLD. It 487
0.8 tr 8.3 3.3 7.9 0.1 0.4 0.4 1.8 0.8 3.1 40.0 11.3 7.0 3.5 7.4 1.0 22.7 77.7
0.1 0.9 9.4 4.7 7.2 tr 1.8 0.8 2.7 0.9 3.2 27.3 17.9 6.6 5.5 9.8 0.9 25.5 74.5
1.2 1.0 4.3 2.0 8.2 -1.6 -3.3 tr 4.0 27.3 19.2 7.6 3.7 9.6 2.8 22.7 77.3
The latter
4.6 0.4 3.5 1.5 3.1 tr 0.5 tr 1.8 0.6 3.3 38.7 16.1 9.0 5.0 9.8 1.8 13.4 86.6
system
is not obvious from our knowledge
Vol. 15, No. 5, 1964
BIOCHEMICAL
of these
systems
affected
more than
have a fatty that it
this is
acid
lipid
with
those
how the
lipid
21-26
fatty
of another.
composition class
the only
acids
however,
AND BIOPHYSICAL acids
of one sphingolipid
The fact
which
most
accumulates
in KLD containing
that
nearly
in MLD via
RESEARCH COMMUNICATIONS
cerebroside
approaches
sulfates normal
a compensatory
appreciable
can be
suggest
synthesis
proportions
since
of fatty
carbons.
TABLE3 COMPARISON OF CONCENTRATIONS OF SPHINGOLLPIDS IN WHITE MATTER IN MLD AS A FUNCTION OF FATTY ACID CHAIN LENGTH
PATTY ACID
SPHINGOMYELIN Case 1 Case 2
CEREBROSIDE CEREBROSIDE SULFATE Case 1 Case 2 Case 1 Case 2
14:o 16tl 16:0 18:l 18rO 20x0 2110 2221 22LO 2311 23:0 2411 2410 25:l 25:0 2611
23 96 92 175 98 59 -15 38 12 37 39 31 47 64 --
6 28 72 47 118 68 --28 -18 14 13 12 -21
54 185 294 613 206 77 92 15 10 60 16 10 10 10 5 10
27 118 167 160 91 19 44 19 8 20 5 5 15 8 -2
5 543 643 267 754 86 --364 380 233 169 267 176 263 241
30 245 141 152 304 353 --212 -140 81 137 97 84 113
14-20 21-26
82 30
75 14
232 13
97 8
456 206
194 102
Values are expressed as percent of the normal concentration for Only unsubstituted fatty acids each compound in white matter. are included. The hydroxy acids of cerebrosides and cerebroside sulfates showed a similar decline with increasing chain length.
The pathogenesis major
forces
carbon of this for
involved
interactions force
interaction
since with
of MLD may be explained in the cohesion
(11).
Fatty
they
present
adjacent
acids
as follows.
of membranes in complex
a large molecules.
surface Long
488
is
that
lipids
One of the due to carbon-
are major
of available chain
fatty
sources
carbon acids
impart
atoms
Vol. 15, No. 5, 1964
greater the
stability
larger
than
the number
addition,
only
to extend
across
with
long
chain
acids
fatty
acids
that
(13,14),
can be made.
lipids
containing
This
very
to white
of cerebrosides leads
It elongation
white
is our
prediction
system
is
matter
has recently lobes
also
effected
one case of infantile
is
findings almost
long
exclus-
isolated
fatty
acid
acids myelin.*
chain
of myelin
chain
these
synthesis
chain
recently
stable
that
of unstable
fatty
we have
containing
before
deficient
long
disorders
point
stable and
to myelin
sphingolipid
in other
sphingo-
a uniquely
localized
very
to the author's of long
chain
one case of globoid-cell
Gauchers
for
formation found
fatty
a
acids
in
disease.
a deficiency of MID,
it
or to formation
the
by very
membrane.
In MID,
(15).
of this
has been brought
in two cases
provided
by the are
containing
that
of sphingolipids
reported
acids
enough
cross-linking
of sphingomyelins
supported
matter
long
This
requirement
since
In
and interdigitate
must be synthesized
of myelination
from Niemann-Picks It
other
in its
acids
fatty
(12).
the myelin
acids is
leaflet
3) and more specifically
In confirmation
deficiency
Addendum.
chain
from white
to cessation
and breakdown. marked
fatty
and sphingomyelins
either
the
chain,
cohesion.
or more are
layer
quantities
hypothesis
(Table
by ultracentrifugation
fatty
sufficient
long
matter
with
the carbon
the
bimolecular
is unique
chain
these
longer
18 carbons
to stabilize
myelin
and that
the
in the opposite leaflet
long
containing
with
of the myelin
may help
very
since
and the greater
acids
bimolecular
myelin
ively
fatty
of lipids
of the
cerebrosides
acids
chain
the center
containing
membrane
short
of interactions
We postulate lipids
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
saturated
the fatty
of one side
BIOCHEMICAL
disease
attention fatty
that acids
Svennerholm from
frontal
leucodystrophy
and
(16).
ACKNOWLEDGEMENTS We are indebted to Dr. Allen this study and for providing
*Analysis progress)
of myelin isolated may shed further
Cracker for his kind encouragement throughout the case material. This project was supported
from MID by ultracentrifugation light on this point. 489
(now
in
Vol. 15, No. 5, 1964
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
by Grant #NB-04136-OlAl from the National Institute of Neurological Diseases and Blindness, Grant #H&08429-01 from the National Heart and Project 61605, Los Angeles County Hospital Attending Staff.
Institute,
REFERENCES 1) O'Brien,J.S., Fillerup,D,L., and Mead,J.F.,.T.Lipid Res.5:109,1964. 2) Rouser,G., Baumann,A.J., Kritchevsky,G., Heller,D. and O'Brien,J.S. J.Am.Oil Chemists'Soc. 38:544,1961. 3) O'Brien,J.S.,Fillerup,Dx.,and Mead,J.F.,J.Lipid Res. In Press. Baumann,A.J.,Nicolaides,N. and Heller,D.,J.Am.Oil 4) Rouser,G., Chemists' Sot. 38:565,1961. 5) Farquahar,J.W.,rLipid Res.3:21,1962. 6) O'Brien,J.S. and Rouser,G.,Anal.Biochem. In Press. 7) Wakil,S.J.,Ann.Rev.Biochem.31:376,1962. 8) Brady,R.O. J.Biol.Chem.235:=99,1960. 9) Fulc0,A.J. and Mead,J.F~.Biol.Chem.236:2416,1961. 10) Hajra,A.K. and Radin,N.S.,J.Lipid ResT270,1963. 11) Salem,L., Can.J.Biochem.Physiol. %:1287,1962. 12) Vandenheuvel,F.A.,J.Am.Oil Chemists' Soc.~:455,1963. 13) Waelsch,H.,Sperry,W.M. and Stoyanoff,V.A.,J.Biol.Chem.135:291,1940. 14) Davison,A.N. and Dobbing,J., Bi0chem.J. 75: 565,196O. 15) O'Brien,J.S., Sampson,E.L. and Connerton,S.R.M., Unpublished data. 16) Svennerholm,L.,Brain Lipids and Lipoproteins and the Leucodystrophies, J.Folch-Pi and H.J.Bauer eds., p 104, Elsevier Pub. Co.Ltd. N.Y. 1963.
490